Related Experiment Video

Updated: Jun 15, 2026

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

Risk factors for red blood cell transfusion after coronary artery bypass graft surgery

Albert H M van Straten1, Suzanne Kats, Margreet W A Bekker

  • 1Department of Cardio-Thoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands.

Journal of Cardiothoracic and Vascular Anesthesia
|March 17, 2010
PubMed

Insights

This study identified preoperative and perioperative risk factors for red blood cell transfusion in coronary artery bypass graft surgery patients. These findings help refine transfusion criteria and improve patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Anesthesiology

Background:

  • Perioperative red blood cell (RBC) transfusion is linked to increased patient morbidity and mortality.
  • Identifying patients at high risk for transfusion is crucial for optimizing resource allocation and patient care.

Purpose of the Study:

  • To investigate the correlation between preoperative risk factors and the number of RBC units transfused.
  • To identify independent risk factors for RBC transfusion in patients undergoing coronary artery bypass graft (CABG) surgery.

Main Methods:

  • Retrospective analysis of prospectively collected data from a single educational hospital.
  • Inclusion of 10,626 patients who underwent isolated CABG surgery between 1998 and 2007.
  • Univariate and multivariate logistic regression analyses to determine risk factors for RBC transfusion.

Main Results:

  • Identified independent preoperative risk factors: advanced age, female sex, low body surface area, low left ventricular ejection fraction (<35%), emergency surgery, prior cardiac surgery, low preoperative hemoglobin, and low creatinine clearance.
  • Identified perioperative risk factors: use of extracorporeal circulation, prolonged bypass time, crystalloid cardioplegia, intra-aortic balloon pump use, perioperative myocardial infarction, and re-exploration.
  • These factors significantly impact the likelihood of receiving RBC units.

Conclusions:

  • Established a comprehensive list of preoperative and perioperative risk factors for RBC transfusion in CABG patients.
  • These identified factors can be integrated into clinical practice to refine transfusion protocols and improve patient safety.
  • Sharpening criteria for RBC availability in the operating room can optimize transfusion management.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...